Analyst Josh Sullivan of Benchmark Co. reiterated a Buy rating on Odysightai (ODYS – Research Report), retaining the price target of $10.00.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Josh Sullivan’s rating is based on Odysightai’s strong performance and strategic shift towards the Aerospace & Defense and Industrial Technology sectors. The company exceeded revenue expectations for the first quarter of 2025, reporting a significant year-over-year increase. This growth was partly due to the full derecognition of a contract liability with a major medical customer, yet even without this impact, Odysightai surpassed revenue estimates.
Additionally, Odysightai has successfully transitioned its focus from healthcare to a robust backlog in Aerospace & Defense and Industrial markets, with notable clients such as the Israeli Air Forces and NASA. The company has also secured a new purchase order from a European industrial client, demonstrating its expanding market reach. With substantial cash reserves, Odysightai is well-positioned to capitalize on global opportunities in predictive and condition-based maintenance, supporting Sullivan’s Buy rating.